Delivery Order SPE2DB20D2104-SPE2DB23FS03E
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,882.35 for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 3, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,961.40 Firm Fixed Price delivery order contract is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has a period of performance through May 14, 2025 and is not set aside for any socioeconomic category. Amerisourcebergen holds a substantial Indefinite Delivery Contract...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The $1,414.56 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 7, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,175.55 firm fixed-price delivery order is for CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has a completion date of July 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,030.20 firm fixed-price delivery order is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,354.57, is a Delivery Order for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 26, 2025. The contract was not designated with a set-aside. AmerisourceBergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,385.39, is a delivery order for CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a medical product, with a period of performance through January 17, 2025. The contract is a firm fixed-price arrangement and was not set aside for any specific business category. Amerisourcebergen holds a $999,999,999 Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,827.72 Firm Fixed Price Delivery Order is for CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of February 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,258.00 firm fixed-price delivery order is for CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of June 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $3,315.29 and covers the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with a completion date of December 4, 2024. The contract is a Delivery Order and has a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS03EDelivery Order
This federal contract award to Amerisourcebergen Drug Corp is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, under a Delivery Order valued at $1,761.36. The contract was awarded by the Defense Logistics Agency (DLA), a Defense agency, and has a completion date of February 2, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific Delivery Order does not have a set-aside designation, indicating open competition. The contract award demonstrates Amerisourcebergen's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, through its extensive supply chain and distribution capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 2/1/23 |